NCT06713785View on ClinicalTrials.gov

Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 26, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hypertension
Interventions
DRUG

Amlodipine

Amlodipine 1mg/ml Oral Solution

Sponsors

Collaborators (1)

Closed Loop Medicine Ltd
All Listed Sponsors
collaborator

INNOVATEUK

UNKNOWN

collaborator

Closed Loop Medicine Ltd

UNKNOWN

lead

Queen Mary University of London

OTHER

NCT06713785 - Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension | Biotech Hunter | Biotech Hunter